LSI Medience Corporation

Site

Anti-Doping Laboratory

Accreditation No.

14243

Site No.

14236

Date of Accreditation

09 Aug 1999

Address

3-29-1 Shimura,, Itabashi-ku,, TOKYO 174-8555 JAPAN 0
Japan

medience.co.jp

Contact

Ms Ayako Ikekita P: 81 359942360

Availability

Services conditionally available to external clients

Scope of Accreditation

ISO/IEC 17025 (2017)

Legal - Analysis for compliance with WADA and sporting federation requirements

Service Product Determinant Technique Procedure
Analysis for sports drugs and drug metabolites Dried blood spots Testosterone esters LC-MS-MS in-house method TK-3B-39
Human blood cDNA-EPO gene detection Polymerase chain reaction (PCR) in-house method TK-3B-35
Haemoglobin based oxygen carriers (HBOCs) LC-MS-MS

 In house DC-3-2027

Blood parameters Sysmex XN 1000

In-house DC-3-2024

Human plasma Erythropoiesis stimulating agents (ESAs) Electrophoresis in-house method TK-3B-36
Human serum IGF-1 (hGH biomarker) LC-MS-MS In house DC-3-2029
Human growth hormone (HGH) biomarkers Radio immunoassay (RIA)

In house DC-3-2029

Human growth hormone (HGH) biomarkers Chemiluminescence

In house DC-3-2029

Human growth hormone (HGH) Immunoassay

 In house DC-3-2023

Human serum; Human urine Erythropoiesis stimulating agents (ESAs) Electrophoresis

 In-house DC-3-2018

Human urine Aromatase inhibitors GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002 and DC-3-2019


Ethylglucuronide (ETG) LC-MS-MS

 In-house DC-3-2019

Selective estrogen receptor modulators GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002 and DC-3-2019

Darbepoetin alfa (NESP)NULL LC-MS-MS

 In house DC-3-2018

Stimulants GC-MS; GC-MS-MS; Gas chromatography (GC); LC-MS-MS

In-house DC-3-2001, DC-3-2002 and DC-3-2019

Formoterol LC-MS-MS

In-house DC-3-2028

Boldenone Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS) in-house method TK-3B-20
Narcotics GC-MS; GC-MS-MS; Gas chromatography (GC); LC-MS-MS

In-house DC-3-2001, DC-3-2002 and DC-3-2019

Morphine; Salbutamol GC-MS; GC-MS-MS

 In house DC-3-2002

Specific gravity Refractometry In-house DC-3-1028
19-Norandrosterone (19-NA) GC-MS-MS

 In house DC-3-2002

Cannabis GC-MS

In-house DC-3-2007

Formestane Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS) in-house method TK-3B-21
EphedrinesNULL LC-MS-MS

In house DC-3-2030

Corticosteroids GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002 and DC-3-2019


Anti-estrogenic substances GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002 and DC-3-2019

Human chorionic gonadotropin (hCG); Human chorionic gonadotropin (hCG) releasing factors; Luteinising hormone (LH); Luteinising hormone (LH) releasing factors Immunoassay

In-house DC-3-2003, DC-3-2009


Steroid profile GC-MS; GC-MS-MS

In-house DC-3-2010

Hydroxylethyl starch (HES) GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002, DC-3-2004 and DC-3-2019

β2-Agonists GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002 and DC-3-2019


Salbutamol LC-MS-MS

 In house DC-3-2019

Diuretics GC-MS; GC-MS-MS; LC-MS-MS

 In-house DC-3-2002 and DC-3-2019

β-Blockers GC-MS; GC-MS-MS; LC-MS-MS

In-house DC-3-2002 and DC-3-2019


19-Norandrosterone (19-NA) Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS)

 In house DC-3-2019

Anabolic steroids GC-MS; GC-MS-MS; Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); LC-MS-MS

In-house DC-3-2002, DC-3-2019 and DC-3-2020

Gonadotropin-releasing hormones (GnRHs); Growth hormone releasing factors - GHRFs, GHSs, GHRPs, GHRHs LC-MS-MS

In-house DC-3-2019


ISO/IEC 17025 (2017)

Legal - Analysis for compliance with WADA and sporting federation requirements

Service Product Determinant Technique Procedure
Analysis for sports drugs and drug metabolites Dried blood spots S1: Anabolic agents LC-MSn (n?1) in-house method TK-3B-39: QP
Human blood M3 Gene and cell doping Polymerase chain reaction (PCR) in-house method TK-3B-35:CP
M1: Manipulation of blood and blood components (hemoglobin-based oxygen carriers) LC-HRMSn (n?1); LC-MSn (n?1); Visual examination in-house methods TK-3B-06:ITP,  TK-3B-15, TK-3B-29:ITP, CP
Blood parameters Sysmex XN 1000

in-house method TK-3B-2027: QP

M1: Manipulation of blood and blood components Flow cytometry in-house method TK-3B-28
Human plasma; Human serum; Human urine S2: Peptide hormones, growth factors, related substances, and mimetics (erythropoiesis stimulating agents - SAR-PAGE, IEF-PAGE) Electrophoresis in-house methods TK-3B-13, TK-3B-36: CP
Human serum S2: Peptide hormones, growth factors, related substances, and mimetics (human growth hormone - isoform) Chemiluminescent immunoassay; Immunoassay; LC-MSn (n?1); Radio immunoassay (RIA) in-house methods:
TK-3B-31, TK-3B-32, TK-3B-33, TK-3B-34, TK-3B-43: QP
Human urine Specific gravity Refractometry in-house method TK-3B-41: ITP, QP
S3: Beta-2 agonists GC-HRMSn (n?1); GC-MSn (n?1); LC-HRMSn (n?1); LC-MSn (n?1) in-house method
TK-3B-06, TK-3B-10: ITP
TK-3B-15, TK-3B-16;CP
TK-3B-23, TK-3B-24:QP
S6: Stimulants GC-HRMSn (n?1); GC-MSn (n?1); LC-HRMSn (n?1); LC-MSn (n?1) in-house methods
TK-3B-06, TK-3B-08, TK-3B-10: ITP
TK-3B-15, TK-3B-16: CP
TK-3B-22: QP
pH pH meter in-house method TK-3B-40
S4: Hormone and metabolic modulators GC-HRMSn (n?1); GC-MSn (n?1); LC-HRMSn (n?1); LC-MSn (n?1) in-house methods TK-3B-06, TK-3B-08, TK-3B-10:ITP
TK-3B-15, TK-3B-16; CP
S5: Diuretics and masking agents LC-HRMSn (n?1); LC-MSn (n?1) in-house methods TK-3B-06, TK-3B-07:ITP
TK-3B-15: CP
S9: Glucocorticoids LC-HRMSn (n?1); LC-MS-MS; LC-MSn (n?1) in-house method TK-3B-06:ITP
TK-3B-15:CP
S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone) LC-HRMSn (n?1); LC-MSn (n?1) in-house methods TK-3B-06, TK3B-07: ITP
TK-3B-15: CP
P1: Beta-blockers LC-HRMSn (n?1); LC-MSn (n?1) in-house methods TK-3B-06: ITP
TK-3B-15: CP
S7: Narcotics GC-HRMSn (n?1); GC-MSn (n?1); LC-HRMSn (n?1); LC-MSn (n?1) in-house methods
TK-3B-06, TK-3B-08, TK-3B-10: ITP
TK-3B-15, TK-3B-16;CP
TK-3B-26: QP

S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone) Immunoassay in-house methods TK-3B-09: ITP; TK-3B-18: QP
S1: Anabolic agents (including steroid profiling) GC-HRMSn (n?1); GC-MSn (n?1); Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); LC-HRMSn (n?1); LC-MSn (n?1) in-house methods:
TK-3B-06, TK-3B-10: ITP
TK-3B-02, TK-3B-14, TK-3B-15, TK-3B-16,TK-3B-17, TK-3B-20, TK-3B-21: CP
TK-3B-19: QP
S8: Cannabinoids GC-MSn (n?1); LC-MSn (n?1) in-house methods:
TK-3B-06, TK-3B-10: ITP
TK-3B-25:QP
S4: Hormone and metabolic modulators LC-HRMSn (n?1) In-house method TK-3B-12

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.